← GE Aerospace

GE · Forward model

Revenue by vertical, 20 quarters out

Model as of

Each segment is projected from its own operating driver, rolled up into consolidated cash flow, and discounted back to a fair value per share. The assumptions below are editable — change them and every number on this page moves with them.

BASIS. This is the hardest thing about GE. General Electric Company spun off GE HealthCare on 3 January 2023 and GE Vernova on 2 April 2024, and current filings present both as discontinued operations. That means two different revenue histories exist for the same quarters: as originally reported, and as recast. Everything here - revenue, EPS, cash flow, margins, and the series on the stock page this model sits behind - is CONTINUING OPERATIONS, GE Aerospace standalone, as recast in the most recent filings. On that basis 2026 Q2 revenue was $13,349m and continuing-operations diluted EPS $2.30. Mixing an as-originally-reported quarter into this series would not look like a rounding error; it would look like a company that shrank by two thirds. FREE CASH FLOW. GE publishes its own non-GAAP free cash flow, $3,027m in the basis quarter, which adds back PP&E disposals, separation cash expenditures and Corporate & Other restructuring cash expenditures. The stock page does not use it. The repository standard is operating cash flow less gross additions to property, plant and equipment: $3,258m less $335m, or $2,923m - $104m (3.4%) below GE's figure, and roughly $0.3-$0.4bn below it on the guided full year. Separately, the FCF line inside THIS model is the projection engine's own construction, EBITDA less capex less tax, so it carries no working capital and no cash interest and should not be read against either of the other two. SEGMENT HISTORY. Two quarters, and that is a disclosure limit rather than a shortcut. Effective 2026 GE moved its Aeroderivative business from CES to DPT and recast only the quarters it has since restated - 2025 Q1, 2025 Q2, 2026 Q1 and 2026 Q2. The recast is material: 2025 Q2 CES went from $7,990m as printed to $7,646m, and DPT from $2,563m to $2,978m. No recast for 2025 Q3 or 2025 Q4 exists in any filing, 8-K or investor document, and the engine requires contiguous history, so the series starts where the current definition starts. It will extend itself as the 2026 Q3 and Q4 filings restate those quarters. The only estimated point in the model is Eliminations & Other for 2026 Q1: GE prints $(519)m, which makes its own segment subtotal foot to $11,615m against the $11,614m it prints elsewhere, so the model uses $(520)m - the exact residual of the disclosed $12,392m GAAP total less the three other disclosed lines. SEASONALITY. None applied, and that is a finding. A centred four-quarter moving average over the fourteen-quarter continuing-operations revenue series does produce a seasonal-looking shape (factors 0.95 / 0.97 / 1.03 / 1.04, signal 0.094 against a worst window spread of 0.037). But a log-linear detrend of the same series - which removes the 3.75%-a-quarter exponential trend exactly rather than locally - gives signal 0.087 against a worst within-quarter spread of 0.108, which is no seasonality at all. The two disagree because the line has accelerated for four straight years, and an accelerating line looks back-half weighted to any moving average. Both external anchors settle it: GE's raised guide implies second-half adjusted revenue only about 7% above the first half, and Street consensus for 2026 Q3 adjusted revenue of $12.29bn is BELOW the $12.63bn just reported. Neither is consistent with a 5% third- and fourth-quarter lift, so the deceleration is carried by the growth rate, where the evidence is. WHAT IS DISCLOSED AND WHAT IS NOT. Every revenue actual is disclosed. Segment EBITDA margins are derived: GE's own guided full-year 2026 segment operating margins plus a depreciation and amortisation allowance taken from the disclosed $625m of first-half company D&A. The Insurance margin (23.9%) and the Eliminations margin (33.0%) are disclosed ratios - $171m over $715m and $(178)m over $(540)m - not judgements. Corporate overhead of 1.1% of revenue is derived so the model reproduces GE's guided $(1.2)-$(1.3)bn Corporate Cost & Eliminations after the eliminations vertical carries its half. The 15% tax rate is rounded up from a 13.2% first-half actual. Long-run growth rates, terminal margins, the 8.5% discount rate and the 20x exit multiple are assumptions. WHERE THE MODEL DISAGREES WITH THE STREET. The base case projects 2026 Q3 GAAP revenue of $13,550m, which is $12,867m of adjusted revenue - about 4.7% above the $12.29bn consensus for that quarter, and 11.2% above the year-ago quarter. The model sides with GE's disclosed order book and supplier input rather than with a consensus that was 8.6% too low on the quarter just reported. TERMINAL CONCENTRATION. 83.0% of base-case enterprise value sits in the terminal value, so the exit multiple deserves more scrutiny than any operating assumption: each 1x is $10.74 a share, and 28.0x is what would justify today's price on the base path.

GE REVENUE MODEL

Latest: $17.33B (2031Q2E)

Period Value
2026Q1 $12.39B
2026Q2 $13.35B
2026Q3E $13.55B
2026Q4E $13.75B
2027Q1E $13.95B
2027Q2E $14.14B
2027Q3E $14.34B
2027Q4E $14.54B
2028Q1E $14.73B
2028Q2E $14.93B
2028Q3E $15.12B
2028Q4E $15.32B
2029Q1E $15.51B
2029Q2E $15.71B
2029Q3E $15.91B
2029Q4E $16.10B
2030Q1E $16.30B
2030Q2E $16.51B
2030Q3E $16.71B
2030Q4E $16.91B
2031Q1E $17.12B
2031Q2E $17.33B
Scenarios

Where each case comes from

Valuation

From cash flow to fair value

Present value of free cash flow, 20 quarters$46.11B
Terminal-year revenue$68.07B
Terminal-year EBITDA$16.91B
Exit multiple, on ebitda20.0x
Terminal value$338.24B
Discounted at 8.5% a year, terminal value becomes$224.94B
Share of enterprise value from the terminal83%
Enterprise value$271.05B
Net cash-$9.81B
Equity value$261.24B
Shares1.05B
Fair value per share$249.51
Against the deployed price of $337.12, as of -26%

An exit EV/EBITDA multiple on the last four projected quarters, discounted at 8.5%. The multiple is the single most sensitive input here: 83.0% of base-case enterprise value sits in the terminal value, and every 1x of exit multiple is worth $10.74 a share. The base case exits at 20x - the middle of the large-cap aerospace band, where RTX trades near 15x, Safran near 18x, TransDigm near 22x and Heico near 30x. That is a deliberate de-rating from the tape: at $335.71 GE's market capitalisation is $348.3bn and its enterprise value about $358bn, roughly 29x model 2026 EBITDA, and running the base case backwards the exit multiple that would justify today's price is 28.0x. The bear case exits at 16x, the bull at 25x and the Culp case at 27x. The revenue path is not where the argument is - it reproduces GE's own guided year to within 0.15% of the top of the operating-profit range - the argument is entirely about what an aftermarket annuity is worth five years out.

Read the other way round: at $337.12 the market is paying 28.2x terminal-year revenue, holding every other assumption on this page fixed. That is the number to argue about.

Quarter by quarter

The projected path

Quarter Commercial Engines & ServicesDefense & Propulsion TechnologiesInsurance (run-off)Eliminations & Other Revenue YoY EBITDA Capex FCF R40 PV of FCF
2026 Q3E $9.93B$3.49B$683M-$550M $13.55B $3.17B $344M $2.40B $2.35B
2026 Q4E $10.12B$3.54B$653M-$559M $13.75B $3.23B $347M $2.45B $2.36B
2027 Q1E $10.31B$3.58B$625M-$569M $13.95B +13% $3.30B $350M $2.50B +31 $2.36B
2027 Q2E $10.49B$3.63B$599M-$578M $14.14B +6% $3.36B $353M $2.56B +24 $2.36B
2027 Q3E $10.68B$3.68B$575M-$587M $14.34B +6% $3.42B $356M $2.61B +24 $2.35B
2027 Q4E $10.86B$3.72B$552M-$596M $14.54B +6% $3.48B $359M $2.65B +24 $2.35B
2028 Q1E $11.04B$3.76B$530M-$605M $14.73B +6% $3.54B $362M $2.70B +24 $2.34B
2028 Q2E $11.22B$3.81B$510M-$614M $14.93B +6% $3.60B $365M $2.75B +24 $2.34B
2028 Q3E $11.40B$3.85B$491M-$623M $15.12B +5% $3.66B $369M $2.80B +24 $2.33B
2028 Q4E $11.58B$3.89B$472M-$632M $15.32B +5% $3.72B $372M $2.85B +24 $2.32B
2029 Q1E $11.76B$3.94B$455M-$641M $15.51B +5% $3.78B $375M $2.90B +24 $2.31B
2029 Q2E $11.94B$3.98B$439M-$650M $15.71B +5% $3.84B $378M $2.94B +24 $2.30B
2029 Q3E $12.12B$4.02B$423M-$659M $15.91B +5% $3.90B $382M $2.99B +24 $2.29B
2029 Q4E $12.30B$4.07B$408M-$668M $16.10B +5% $3.96B $385M $3.04B +24 $2.28B
2030 Q1E $12.48B$4.11B$394M-$677M $16.30B +5% $4.02B $389M $3.09B +24 $2.27B
2030 Q2E $12.66B$4.15B$381M-$686M $16.51B +5% $4.08B $392M $3.13B +24 $2.26B
2030 Q3E $12.84B$4.20B$368M-$695M $16.71B +5% $4.14B $396M $3.18B +24 $2.25B
2030 Q4E $13.02B$4.24B$355M-$704M $16.91B +5% $4.20B $400M $3.23B +24 $2.24B
2031 Q1E $13.20B$4.29B$343M-$713M $17.12B +5% $4.26B $404M $3.28B +24 $2.22B
2031 Q2E $13.39B$4.33B$332M-$722M $17.33B +5% $4.32B $408M $3.32B +24 $2.21B

Every row is projected. A year-over-year change is shown only where the quarter it compares against exists — an em dash means there is no comparable quarter, not a flat year.

Track record

Model revisions

Assumptions are marked to reality as each quarter prints. Every change is appended here, with the fair value the model produced at the time, so the model's own history stays visible.

DateFair value thenNote
2026-09-01 $249.51 Initial model, built on continuing operations as recast after the GE HealthCare and GE Vernova separations. Four verticals - CES, DPT, run-off Insurance and Eliminations & Other - which are GE's own reporting lines and foot exactly to GAAP total revenue in the basis quarter. History is two quarters because GE moved its Aeroderivative business from CES to DPT effective 2026 and has never recast 2025 Q3 or Q4. Base case reproduces the guided year: 2026 adjusted revenue $50,211m against a high-teens guide, and total operating profit $10,734m against a guided $10.55-$10.75bn.